AtG Therapeutics
At AtG, we develop novel classes of medicines and biomarkers to prevent cancer therapeutic resistance. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD4—6m (Dealroom.co estimates Jul 2022.)
Company register number B09735895
L'Hospitalet de Llobregat Catalonia (HQ)
Authorizing premium user...